Announcements Trials
Browse Landscape

Status

Completed 4Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Brain Neoplasms 4Ototoxicity 1Neurocognitive Disorders 1Neoplasms 1Neoplasm Metastasis 1Meningioma 1Cognitive/Functional Effects 1Cognitive Dysfunction 1Central Nervous System Neoplasms 1Central Nervous System Carcinoma 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

pembrolizumab 25Cyclophosphamide 20Nivolumab 13Doxorubicin 13Carboplatin 10Surveys and Questionnaires 9Paclitaxel 9Exercise 9atezolizumab 8Vincristine 8Rituximab 8Radiotherapy 8Prednisone 8Dexamethasone 8Bevacizumab 8venetoclax 7fludarabine 7Pemetrexed 7Fluorouracil 7Docetaxel 7Blood Specimen Collection 7lenvatinib 6dostarlimab 6cemiplimab 6budigalimab 6Oxaliplatin 6Cisplatin 6durvalumab 5Leucovorin 5Lenalidomide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Neoplasms × Mental Status and Dementia Tests × Clear all
NCT00772200 2025-09-18

Neuropsychological and Behavioral Testing in Younger Patients With Cancer

Children's Oncology Group

Active not recruiting
1,200 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡